Work

BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC.

Year: 2016

Type: article

Authors: Gianni Binotto, Mario Tiribelli, Massimiliano Bonifacio, Luca Frison, M. Narbergoj, Federico De Marchi, Luigi Scaffidi, Marta Medeot, Elena Maino, Elisabetta Calistri, Angela Bonalumi, Mauro Krampera, Achille Ambrosetti, Renato Fanin, Gianpietro Semenzato

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2901199378

FWCI: 0.461

Cites:

Cited by: 2

Related to: 10